| Disease | hemophagocytic lymphohistiocytosis |
| Comorbidity | C0024314|lymphoproliferative disorder |
| Sentences | 1 |
| PubMedID- 24169729 | The emergence of cd20-/cd19- tumor cells after rituximab therapy for epstein-barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis. |
Page: 1